Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine

被引:77
作者
Bonter, Katherine [1 ]
Desjardins, Clarissa [1 ]
Currier, Nathan [1 ]
Pun, Jason [2 ]
Ashbury, Fredrick D. [2 ,3 ,4 ]
机构
[1] Ctr Excellence Personalized Med Cepmed, Montreal, PQ, Canada
[2] PricewaterhouseCoopers LLP, Toronto, ON, Canada
[3] Univ Calgary, Dept Oncol, Div Prevent Oncol, Calgary, AB, Canada
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2011年 / 1卷 / 01期
关键词
D O I
10.1136/bmjopen-2011-000110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: In order to provide baseline data on genetic testing as a key element of personalised medicine (PM), Canadian physicians were surveyed to determine roles, perceptions and experiences in this area. The survey measured attitudes, practice, observed benefits and impacts, and barriers to adoption. Methods: A self-administered survey was provided to Canadian oncologists, cardiologists and family physicians and responses were obtained online, by mail or by fax. The survey was designed to be exploratory. Data were compared across specialties and geography. Results: The overall response rate was 8.3%. Of the respondents, 43%, 30% and 27% were family physicians, cardiologists and oncologists, respectively. A strong majority of respondents agreed that genetic testing and PM can have a positive impact on their practice; however, only 51% agreed that there is sufficient evidence to order such tests. A low percentage of respondents felt that they were sufficiently informed and confident practicing in this area, although many reported that genetic tests they have ordered have benefited their patients. Half of the respondents agreed that genetic tests that would be useful in their practice are not readily available. A lack of practice guidelines, limited provider knowledge and lack of evidence-based clinical information were cited as the main barriers to practice. Differences across provinces were observed for measures relating to access to testing and the state of practice. Differences across specialties were observed for the state of practice, reported benefits and access to testing. Conclusions: Canadian physicians recognise the benefits of genetic testing and PM; however, they lack the education, information and support needed to practice effectively in this area. Variability in practice and access to testing across specialties and across Canada was observed. These results support a need for national strategies and resources to facilitate physician knowledge, training and practice in PM.
引用
收藏
页数:7
相关论文
共 39 条
  • [1] Technology assessment and resource allocation for predictive genetic testing: A study of the perspectives of Canadian genetic health care providers
    Adair, Alethea
    Hyde-Lay, Robyn
    Einsiedel, Edna
    Caulfield, Timothy
    [J]. BMC MEDICAL ETHICS, 2009, 10
  • [2] Is personalized medicine finally arriving?
    Allison, Malorye
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (05) : 509 - 517
  • [3] [Anonymous], 2008, MOL ONC TASK FORC RE
  • [4] [Anonymous], 1995, DIFFUSION INNOVATION
  • [5] Progress towards personalized medicine
    Bates, Stewart
    [J]. DRUG DISCOVERY TODAY, 2010, 15 (3-4) : 115 - 120
  • [6] Personalized Medicine in Oncology: A Personal View with Myths and Facts
    Beijnen, Jos H.
    Schellens, Jan H. M.
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03): : 141 - 147
  • [7] Awareness and Utilization of BRCA1/2 Testing Among US Primary Care Physicians
    Bellcross, Cecelia A.
    Kolor, Katherine
    Goddard, Katrina A. B.
    Coates, Ralph J.
    Reyes, Michele
    Khoury, Muin J.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2011, 40 (01) : 61 - 66
  • [8] Current progress in pharmacogenetics
    Blakey, John D.
    Hall, Ian P.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 824 - 831
  • [9] Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk.
    Bloss, Cinnamon S.
    Schork, Nicholas J.
    Topol, Eric J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) : 524 - 534
  • [10] CARROLL JC, 2008, J COMMUNITY GENET, V11, P43, DOI DOI 10.1159/000111639